A fatty liver leads to a broken heart?

Journal of Hepatology

Volumn 65, Issue 1, 2016, Pages 14-16

  Adams, Leon A ^a   Anstee, Quentin M ^b  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

Cardiovascular disease; Carotid intimal media thickness; NAFLD

Indexed keywords

ALPHA TOCOPHEROL; ANTIHYPERTENSIVE AGENT; PIOGLITAZONE;

ATHEROSCLEROSIS; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; EDITORIAL; ENDOTHELIAL DYSFUNCTION; HEART INFARCTION; HUMAN; HYPERTENSION; NONALCOHOLIC FATTY LIVER; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); CAROTID ARTERY DISEASE;

CAROTID ARTERY DISEASES; HUMANS; NON-ALCOHOLIC FATTY LIVER DISEASE;

EID: 84975057070     PISSN: 01688278     EISSN: 16000641     Source Type: Journal    
DOI: 10.1016/j.jhep.2016.03.012     Document Type: Editorial

References (25)

1. Q.M. Anstee, G. Targher, and C.P. Day Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis Nat Rev Gastroenterol Hepatol 10 2013 330 344
2. L.A. Adams, J.F. Lymp, J. St Sauver, S.O. Sanderson, K.D. Lindor, A. Feldstein, and et al. The natural history of nonalcoholic fatty liver disease: a population-based cohort study Gastroenterology 129 2005 113 121
3. R. Pais, P. Giral, J.-F. Khan, D. Rosenbaum, C. Housset, T. Poynard, and et al. Fatty liver as an independent predictor of early carotid atherosclerosis: results from a large transversal and long-term follow-up J Hepatol 65 2016 95 102
4. M.W. Lorenz, H.S. Markus, M.L. Bots, M. Rosvall, and M. Sitzer Prediction of clinical cardiovascular events with carotid intima-media thickness: a systematic review and meta-analysis Circulation 115 2007 459 467
5. G. Bedogni, S. Bellentani, L. Miglioli, F. Masutti, M. Passalacqua, A. Castiglione, and et al. The Fatty Liver Index: a simple and accurate predictor of hepatic steatosis in the general population BMC Gastroenterol 6 2006 33
6. D.J. Cuthbertson, M.O. Weickert, D. Lythgoe, V.S. Sprung, R. Dobson, F. Shoajee-Moradie, and et al. External validation of the fatty liver index and lipid accumulation product indices, using 1H-magnetic resonance spectroscopy, to identify hepatic steatosis in healthy controls and obese, insulin-resistant individuals Eur J Endocrinol 171 2014 561 569
7. M.T. Long, N. Wang, M.G. Larson, G.F. Mitchell, J. Palmisano, R.S. Vasan, and et al. Nonalcoholic fatty liver disease and vascular function: cross-sectional analysis in the Framingham heart study Arterioscler Thromb Vasc Biol 35 2015 1284 1291
8. R.C. Huang, L.J. Beilin, O. Ayonrinde, T.A. Mori, J.K. Olynyk, S. Burrows, and et al. Importance of cardiometabolic risk factors in the association between nonalcoholic fatty liver disease and arterial stiffness in adolescents Hepatology 58 2013 1306 1314
9. L.B. VanWagner, J.E. Wilcox, L.A. Colangelo, D.M. Lloyd-Jones, J.J. Carr, J.A. Lima, and et al. Association of nonalcoholic fatty liver disease with subclinical myocardial remodeling and dysfunction: A population-based study Hepatology 62 2015 773 783
10. E.T. Oni, A.S. Agatston, M.J. Blaha, J. Fialkow, R. Cury, A. Sposito, and et al. A systematic review: burden and severity of subclinical cardiovascular disease among those with nonalcoholic fatty liver; should we care? Atherosclerosis 230 2013 258 267
11. E. Fabbrini, J. Yoshino, M. Yoshino, F. Magkos, C. Tiemann Luecking, D. Samovski, and et al. Metabolically normal obese people are protected from adverse effects following weight gain J Clin Invest 125 2015 787 795
12. E. Vanni, A. Marengo, L. Mezzabotta, and E. Bugianesi Systemic complications of nonalcoholic fatty liver disease: when the liver is not an innocent bystander Semin Liver Dis 35 2015 236 249
13. D. Kim, W.R. Kim, H.J. Kim, and T.M. Therneau Association between noninvasive fibrosis markers and mortality among adults with nonalcoholic fatty liver disease in the United States Hepatology 57 2013 1357 1365
14. G. Targher, L. Bertolini, F. Poli, S. Rodella, L. Scala, R. Tessari, and et al. Nonalcoholic fatty liver disease and risk of future cardiovascular events among type 2 diabetic patients Diabetes 54 2005 3541 3546
15. R. Haring, H. Wallaschofski, M. Nauck, M. Dorr, S.E. Baumeister, and H. Volzke Ultrasonographic hepatic steatosis increases prediction of mortality risk from elevated serum gamma-glutamyl transpeptidase levels Hepatology 50 2009 1403 1411
16. M. Hamaguchi, T. Kojima, N. Takeda, C. Nagata, J. Takeda, H. Sarui, and et al. Nonalcoholic fatty liver disease is a novel predictor of cardiovascular disease World J Gastroenterol 13 2007 1579 1584
17. P. Pisto, M. Santaniemi, R. Bloigu, O. Ukkola, and Y.A. Kesaniemi Fatty liver predicts the risk for cardiovascular events in middle-aged population: a population-based cohort study BMJ Open 4 2014 e004973
18. Y.L. Liu, H.L. Reeves, A.D. Burt, D. Tiniakos, S. McPherson, J.B. Leathart, and et al. TM6SF2 rs58542926 influences hepatic fibrosis progression in patients with non-alcoholic fatty liver disease Nat Commun 5 2014 4309
19. O.L. Holmen, H. Zhang, Y. Fan, D.H. Hovelson, E.M. Schmidt, W. Zhou, and et al. Systematic evaluation of coding variation identifies a candidate causal variant in TM6SF2 influencing total cholesterol and myocardial infarction risk Nat Genet 46 2014 345 351
20. P. Dongiovanni, S. Petta, C. Maglio, A.L. Fracanzani, R. Pipitone, E. Mozzi, and et al. Transmembrane 6 superfamily member 2 gene variant disentangles nonalcoholic steatohepatitis from cardiovascular disease Hepatology 61 2015 506 514
21. B. Kahali, Y.L. Liu, A.K. Daly, C.P. Day, Q.M. Anstee, and E.K. Speliotes TM6SF2: catch-22 in the fight against nonalcoholic fatty liver disease and cardiovascular disease? Gastroenterology 148 2015 679 684
22. Q.M. Anstee, D. Seth, and C.P. Day Genetic factors that affect risk of alcoholic and non-alcoholic fatty liver disease Gastroenterology 2016 10.1053/j.gastro.2016.01.037 Feb 9. pii: S0016-5085(16)00138-4; [Epub ahead of print]
23. D. Zhao, J. Liu, W. Xie, and Y. Qi Cardiovascular risk assessment: a global perspective Nat Rev Cardiol 12 2015 301 311
24. S. Treeprasertsuk, S. Leverage, L.A. Adams, K.D. Lindor, J. St Sauver, and P. Angulo The Framingham risk score and heart disease in nonalcoholic fatty liver disease Liver Int 32 2012 945 950
25. K.E. Corey, R. Vuppalanchi, L.A. Wilson, O.W. Cummings, and N. Chalasani NASH resolution is associated with improvements in HDL and triglyceride levels but not improvement in LDL or non-HDL-C levels Aliment Pharmacol Ther 41 2015 301 309